Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999478 · ClinicalTrials.gov registry record
Novel Biophotonics Methodology for Colon Cancer Screening
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT01999478 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 4,000 participants.
The verdict
NCT01999478 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before colonoscopy to identify subjects who do and do not have precancerous changes in the colon by capturing the light reflected back from the rectal wall and that will be assessed without the need for colonoscopy and bowel preparation (colon cleaning). This device may detect early cancerous changes in colon tissue with higher accuracy than current tests.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2008-02 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999478
The ClinicalTrials.gov registry entry for NCT01999478 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01999478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01999478 about?
NCT01999478 is a clinical study titled "Novel Biophotonics Methodology for Colon Cancer Screening". The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before...
What is the current status of trial NCT01999478?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2008-02. Estimated completion is 2015-02.
Who is sponsoring clinical trial NCT01999478?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.